Arcadia Biosciences (RKDA) Misses Q1 EPS by 178c

Arcadia Biosciences (NASDAQ: RKDA) reported Q1 EPS of ($1.78). Revenue for the quarter came in at $1.26 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI